March 10, 2020 / 8:17 PM / 25 days ago

BRIEF-Paratek Pharmaceuticals Announces Submission Of Pre-Emergency Use Authorization Application To FDA For Nuzyra

March 10 (Reuters) - Paratek Pharmaceuticals Inc:

* PARATEK PHARMACEUTICALS ANNOUNCES THE SUBMISSION OF THE PRE-EMERGENCY USE AUTHORIZATION APPLICATION TO THE FDA FOR NUZYRA• (OMADACYCLINE)

* PARATEK - PURCHASE OF FIRST 2,500 TREATMENT COURSES OF NUZYRA WILL TAKE PLACE UPON ACCEPTANCE OF PRE-EUA, WHICH IS EXPECTED IN FIRST HALF OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below